PFE:NYE-Pfizer Inc (USD)

COMMON STOCK | Drug Manufacturers—General | NYE

Last Closing Price

USD 40.51

Change

0.00 (0.00)%

Market Cap

USD 224.19B

Volume

0.02B

Average Target Price

USD 41.91 (+3.46%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as Merck KGaA, Nektar Therapeutics, and Syapse, Inc., as well as collaboration agreement with eFFECTOR Therapeutics, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-01-18 )

Largest Industry Peers for Drug Manufacturers—General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
JNJ Johnson & Johnson

N/A

USD392.60B 28.45 14.33
MRK Merck & Co., Inc

N/A

USD231.61B 25.42 13.87
NVS Novartis AG

N/A

USD217.18B 18.93 13.36
BMY Bristol-Myers Squibb Company

N/A

USD156.40B 19.28 13.13
LLY Eli Lilly and Company

N/A

USD134.02B 16.91 20.15
AZN AstraZeneca PLC

N/A

USD134.01B 64.40 35.87
ABBV AbbVie Inc

N/A

USD130.14B 40.42 10.24
SNY Sanofi

N/A

USD128.06B 26.41 -27.24
GSK GlaxoSmithKline plc

N/A

USD119.46B 48.28 168.23
AGN Allergan plc

N/A

USD63.25B 22.00 11.51

ETFs Containing PFE

Symbol Name Weight Mer Price(Change) Market Cap
IBDK iShares iBonds Dec 2019 T.. 14.74 % 0.10 %

N/A

USD0.63B
GNRX VanEck Vectors Generic Dr.. 9.65 % 0.55 %

N/A

USD3.35M
FTXH First Trust Nasdaq Pharma.. 7.75 % 0.60 %

N/A

USD9.40M
SXLV:LSE SSgA SPDR ETFs Europe II .. 5.88 % 0.15 %

N/A

USD0.18B
IUHC:LSE iShares S&P 500 Healt.. 5.87 % 0.15 %

N/A

USD0.96B
ZPDH:F SPDR S&P U.S. Health .. 5.84 % 0.15 %

N/A

USD0.17B
ZPDH:XETRA SPDR S&P U.S. Health .. 5.84 % 0.15 %

N/A

USD0.17B
CURE Direxion Daily Healthcare.. 5.81 % 1.08 %

N/A

USD0.17B
QDVG:F iShares S&P 500 Healt.. 5.79 % 0.15 %

N/A

USD1.14B
IHCU:LSE iShares S&P 500 Healt.. 5.79 % 0.15 %

N/A

USD1.14B
QDVG:XETRA iShares S&P 500 Healt.. 5.79 % 0.15 %

N/A

USD1.14B
XUHC:LSE Xtrackers MSCI USA Health.. 5.78 % 0.12 %

N/A

USD0.36B
XLV Health Care Select Sector.. 5.71 % 0.13 %

N/A

USD20.07B
XUHC:XETRA Xtrackers MSCI USA Health.. 5.52 % 0.12 %

N/A

USD0.43B
XSHC:LSE Xtrackers MSCI USA Health.. 5.52 % 0.12 %

N/A

USD0.43B
XHD:CA iShares U.S. High Dividen.. 5.33 % 0.33 %

N/A

USD0.21B
RXL ProShares Ultra Health Ca.. 5.33 % 0.95 %

N/A

USD0.12B
XHU:CA iShares U.S. High Dividen.. 5.32 % 0.33 %

N/A

USD0.09B
HDV iShares Core High Dividen.. 5.30 % 0.08 %

N/A

USD7.83B
RXD ProShares UltraShort Heal.. 5.27 % 0.95 %

N/A

USD1.90M
RXD ProShares UltraShort Heal.. 5.27 % 0.95 %

N/A

USD1.90M
IYH iShares U.S. Healthcare E.. 5.26 % 0.43 %

N/A

USD2.22B
PPH VanEck Vectors Pharmaceut.. 5.03 % 0.36 %

N/A

USD0.20B
DHS WisdomTree U.S. High Divi.. 4.98 % 0.38 %

N/A

USD0.96B
FHI:CA CI First Asset Health Car.. 4.94 % 0.75 %

N/A

USD0.20B
FHI-B:CA CI First Asset Health Car.. 4.94 % 0.81 %

N/A

N/A
DJD Invesco Dow Jones Industr.. 4.90 % 0.07 %

N/A

USD0.09B
VHT Vanguard Health Care Inde.. 4.85 % 0.10 %

N/A

USD11.48B
FHLC Fidelity MSCI Health Care.. 4.84 % 0.08 %

N/A

USD1.69B
PJP Invesco Dynamic Pharmaceu.. 4.80 % 0.56 %

N/A

USD0.38B
PBE Invesco Dynamic Biotechno.. 4.80 % 0.57 %

N/A

USD0.24B
XMDU:XETRA Xtrackers (IE) Public Lim.. 4.73 % 0.35 %

N/A

USD5.13M
DURA VanEck Vectors Morningsta.. 4.62 % 0.29 %

N/A

USD0.02B
SCHD Schwab U.S. Dividend Equi.. 4.52 % 0.06 %

N/A

USD11.62B
XMDU:F Xtrackers Morningstar US .. 4.46 % 0.35 %

N/A

USD5.00M
IHE iShares U.S. Pharmaceutic.. 4.42 % 0.42 %

N/A

USD0.37B
OSXC:XETRA Ossiam Risk Weighted Enha.. 4.31 % 0.45 %

N/A

N/A
JHMH John Hancock Multifactor .. 4.29 % 0.40 %

N/A

USD0.04B
HUL:CA Harvest US Equity Plus In.. 4.23 % 2.20 %

N/A

USD7.80M
HUL-U:CA Harvest US Equity Plus In.. 4.23 % 2.23 %

N/A

N/A
BVNSC Brandes Value NextShares 4.19 % 0.41 %

N/A

USD4.83M
XPH SPDR S&P Pharmaceuticals .. 4.14 % 0.35 %

N/A

USD0.22B
XDWH:LSE Xtrackers MSCI World Heal.. 3.94 % 0.30 %

N/A

USD0.35B
XHC:CA iShares Global Healthcare.. 3.93 % 0.65 %

N/A

USD0.31B
IXJ iShares Global Healthcare.. 3.87 % 0.46 %

N/A

USD2.12B
WHEA:LSE SPDR MSCI World Health Ca.. 3.87 % 0.30 %

N/A

USD0.12B
ISUS:LSE iShares MSCI USA Islamic .. 3.82 % 0.50 %

N/A

USD0.07B
XDWH:XETRA Xtrackers MSCI World Heal.. 3.79 % 0.30 %

N/A

USD0.48B
XDWH:F Xtrackers MSCI World Heal.. 3.79 % 0.30 %

N/A

USD0.48B
SPHQ Invesco S&P 500 Quality E.. 3.41 % 0.15 %

N/A

USD1.83B
ISDU:LSE iShares MSCI USA Islamic .. 3.38 % 0.50 %

N/A

USD0.07B
PWV Invesco Dynamic Large Cap.. 3.33 % 0.55 %

N/A

USD1.13B
PILL Direxion Daily Pharmaceut.. 3.31 % 0.99 %

N/A

USD0.02B
JKF iShares Morningstar Large.. 3.03 % 0.25 %

N/A

USD0.56B
OUSA O'Shares FTSE U.S. Qualit.. 3.00 % 0.48 %

N/A

USD0.59B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.86 % 0.35 %

N/A

N/A
UBUS:F UBS (Irl) ETF plc - Facto.. 2.86 % 0.25 %

N/A

N/A
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.86 % 0.25 %

N/A

N/A
UBUW:F UBS (Irl) ETF plc - Facto.. 2.86 % 0.35 %

N/A

N/A
UC96:LSE UBS (Irl) ETF plc - Facto.. 2.86 % 0.25 %

N/A

N/A
XDU:CA iShares Core MSCI US Qual.. 2.82 % 0.14 %

N/A

USD0.07B
QDVD:XETRA iShares MSCI USA Quality .. 2.81 % 0.35 %

N/A

USD0.44B
XDUH:CA iShares Core MSCI US Qual.. 2.81 % 0.14 %

N/A

USD0.02B
HDIQ:LSE iShares MSCI USA Quality .. 2.81 % 0.35 %

N/A

USD0.44B
QDVD:F iShares MSCI USA Quality .. 2.81 % 0.35 %

N/A

USD0.44B
XDND:XETRA Xtrackers MSCI North Amer.. 2.76 % 0.39 %

N/A

USD0.06B
XDND:F Xtrackers MSCI North Amer.. 2.76 % 0.39 %

N/A

USD0.06B
XDND:LSE Xtrackers MSCI North Amer.. 2.76 % 0.39 %

N/A

USD0.06B
ZISG:LSE BMO MSCI USA Income Leade.. 2.74 % 0.40 %

N/A

USD2.19M
ZILS:LSE BMO MSCI USA Income Leade.. 2.72 % 0.35 %

N/A

USD0.03B
ZPRU:XETRA SPDR MSCI USA Value UCITS.. 2.55 % 0.25 %

N/A

USD0.04B
UVAL:LSE SPDR MSCI USA Value UCITS.. 2.55 % 0.25 %

N/A

USD0.04B
ZPRU:F SPDR MSCI USA Value UCITS.. 2.55 % 0.25 %

N/A

USD0.04B
IUVL:LSE iShares Edge MSCI USA Val.. 2.55 % 0.20 %

N/A

USD0.83B
RWDC Direxion MSCI Defensives .. 2.55 % 0.45 %

N/A

USD0.01B
USVL:LSE SPDR MSCI USA Value UCITS.. 2.54 % 0.25 %

N/A

USD0.03B
ZVU:CA BMO MSCI USA Value Index .. 2.49 % 0.33 %

N/A

USD0.01B
QDVI:F iShares Edge MSCI USA Val.. 2.49 % 0.20 %

N/A

USD1.57B
QDVI:XETRA iShares Edge MSCI USA Val.. 2.49 % 0.20 %

N/A

USD1.57B
IUVF:LSE iShares Edge MSCI USA Val.. 2.49 % 0.20 %

N/A

USD1.57B
HID:CA WisdomTree U.S. High Divi.. 2.49 % 0.40 %

N/A

USD4.31M
IUVD:LSE iShares Edge MSCI USA Val.. 2.49 % 0.20 %

N/A

USD1.57B
WTD9:XETRA WisdomTree US Equity Inco.. 2.47 % 0.29 %

N/A

N/A
HID-B:CA WisdomTree U.S. High Divi.. 2.47 % 0.40 %

N/A

N/A
WTDY:F WisdomTree US Equity Inco.. 2.47 % 0.35 %

N/A

N/A
WTD9:F WisdomTree US Equity Inco.. 2.47 % 0.29 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 2.47 % 0.29 %

N/A

N/A
WTEU:F WisdomTree US Equity Inco.. 2.47 % 0.29 %

N/A

N/A
WTEU:XETRA WisdomTree US Equity Inco.. 2.47 % 0.29 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 2.47 % 0.29 %

N/A

N/A
WTDY:XETRA WisdomTree US Equity Inco.. 2.47 % 0.35 %

N/A

N/A
UPVL:LSE UBS (Irl) ETF plc - Facto.. 2.44 % 0.35 %

N/A

N/A
HLAL Wahed FTSE USA Shariah ET.. 2.39 % 0.50 %

N/A

USD0.02B
DHSD:LSE WisdomTree US Equity Inco.. 2.36 % 0.29 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 2.36 % 0.29 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 2.36 % 0.35 %

N/A

N/A
DGRO iShares Core Dividend Gro.. 2.31 % 0.08 %

N/A

USD10.33B
XDG:CA iShares Core MSCI Global .. 2.30 % 0.20 %

N/A

USD0.11B
XDWY:XETRA Xtrackers MSCI World High.. 2.30 % 0.29 %

N/A

USD0.03B
XDWY:LSE Xtrackers MSCI World High.. 2.30 % 0.29 %

N/A

USD0.03B
XDGH:CA iShares Core MSCI Global .. 2.29 % 0.20 %

N/A

USD0.04B
WQDS:LSE iShares MSCI World Qualit.. 2.29 % 0.38 %

N/A

USD0.09B
PEU-B:CA Purpose Enhanced US Equit.. 2.24 % 1.16 %

N/A

N/A
WQDV:LSE iShares MSCI World Qualit.. 2.16 % 0.38 %

N/A

USD0.07B
VYM Vanguard High Dividend Yi.. 2.01 % 0.06 %

N/A

USD39.64B
5HEE:XETRA Ossiam ESG Low Carbon Shi.. 1.94 % 0.00 %

N/A

N/A
DEW WisdomTree Global High Di.. 1.93 % 0.58 %

N/A

USD0.09B
ISWD:LSE iShares MSCI World Islami.. 1.87 % 0.60 %

N/A

USD0.15B
IWVU:LSE iShares Edge MSCI World V.. 1.76 % 0.30 %

N/A

USD1.95B
IWVL:LSE iShares Edge MSCI World V.. 1.76 % 0.30 %

N/A

USD1.95B
FDRR Fidelity Dividend ETF for.. 1.75 % 0.29 %

N/A

USD0.37B
ISDW:LSE iShares MSCI World Islami.. 1.73 % 0.60 %

N/A

USD0.12B
SPYV SPDR Portfolio S&P 500 Va.. 1.72 % 0.04 %

N/A

USD5.01B
VOOV Vanguard S&P 500 Value In.. 1.72 % 0.10 %

N/A

USD1.34B
IVE iShares S&P 500 Value ETF 1.71 % 0.18 %

N/A

USD17.87B
DLN WisdomTree U.S. LargeCap .. 1.70 % 0.28 %

N/A

USD2.40B
IS3S:XETRA iShares Edge MSCI World V.. 1.69 % 0.30 %

N/A

USD2.38B
XDEV:LSE Xtrackers MSCI World Valu.. 1.69 % 0.25 %

N/A

USD0.41B
XDEV:F Xtrackers MSCI World Valu.. 1.69 % 0.25 %

N/A

USD0.41B
XDEV:XETRA Xtrackers MSCI World Valu.. 1.69 % 0.25 %

N/A

USD0.41B
IWFV:LSE iShares Edge MSCI World V.. 1.69 % 0.30 %

N/A

USD2.38B
IWVG:LSE iShares Edge MSCI World V.. 1.69 % 0.30 %

N/A

USD2.38B
IS3S:F iShares Edge MSCI World V.. 1.69 % 0.30 %

N/A

USD2.38B
IUSV iShares Core S&P U.S. Val.. 1.60 % 0.04 %

N/A

USD7.03B
FGBL:LSE First Trust Global Equity.. 1.55 % 0.60 %

N/A

USD0.02B
GINC:LSE First Trust Global Equity.. 1.55 % 0.70 %

N/A

USD0.02B
FGBL:PA First Trust Global Equity.. 1.55 % 0.60 %

N/A

USD0.02B
RNDV First Trust US Equity Div.. 1.53 % 0.50 %

N/A

USD4.80M
FQAL Fidelity Quality Factor E.. 1.48 % 0.29 %

N/A

USD0.16B
JVAL JPMorgan U.S. Value Facto.. 1.46 % 0.12 %

N/A

USD0.08B
DTD WisdomTree U.S. Total Div.. 1.42 % 0.28 %

N/A

USD0.80B
ROUS Hartford Multifactor US E.. 1.25 % 0.19 %

N/A

USD0.34B
USFM:LSE UBS (Irl) ETF plc - MSCI .. 1.12 % 0.30 %

N/A

N/A
BSCJ Invesco BulletShares 2019.. 0.85 % 0.10 %

N/A

USD0.92B
PYF:CA Purpose Premium Yield Fun.. 0.81 % 0.73 %

N/A

USD0.14B
PYF-B:CA Purpose Premium Yield Fun.. 0.81 % 0.76 %

N/A

N/A
PYF-U:CA Purpose Premium Yield Fun.. 0.81 % 0.72 %

N/A

N/A
UIQM:XETRA UBS (Irl) ETF plc - MSCI .. 0.65 % 0.00 %

N/A

USD0.03B
QDVW:XETRA iShares II Public Limited.. 0.00 % 0.00 %

N/A

N/A
CRWE:PA Ossiam Risk Weighted Enha.. 0.00 % 0.45 %

N/A

N/A
LVL Invesco S&P Global Divide.. 0.00 % 0.64 %

N/A

USD0.03B
OSXC:F Ossiam Risk Weighted Enha.. 0.00 % 0.45 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers—General)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.39% 82% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.39% 82% B- 75% C
Trailing 12 Months  
Capital Gain -4.75% 9% F 21% F
Dividend Return 3.39% 60% D- 66% D
Total Return -1.36% 9% F 22% F
Trailing 5 Years  
Capital Gain 23.51% 55% F 63% D
Dividend Return 19.51% 82% B- 68% D+
Total Return 43.02% 55% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 4.95% 55% F 63% D
Dividend Return 3.69% 73% C 70% C-
Total Return 8.63% 55% F 66% D
Risk Return Profile  
Volatility (Standard Deviation) 12.11% 82% B- 64% D
Risk Adjusted Return 71.31% 64% D 72% C-
Market Capitalization 224.19B 82% B- 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers—General)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 14.33 100% A+ 64% D
Price/Book Ratio 3.44 73% C 27% F
Price / Cash Flow Ratio 14.16 73% C 33% F
EV/EBITDA 12.07 73% C 41% F
Management Effectiveness  
Return on Equity 23.70% 60% D- 89% B+
Return on Invested Capital 14.30% 55% F 83% B
Return on Assets 5.94% 36% F 81% B-
Debt to Equity Ratio 52.51% 45% F 62% D-
Technical Ratios  
Short Ratio 3.25 64% D 41% F
Short Percent 1.03% 82% B- 87% B+
Beta 0.65 45% F 68% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

STA Verdict Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.